Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
35.30
+0.92 (2.68%)
Dec 31, 2025, 12:08 PM HKT

HKG:2315 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
23,5853,3954,78510,245--
Market Cap Growth
866.46%-29.05%-53.29%---
Enterprise Value
23,7293,5624,68210,003--
Last Close Price
35.308.5011.9825.65--
PE Ratio
96.7395.11----
PS Ratio
18.073.256.0616.97--
PB Ratio
24.013.805.507.87--
P/TBV Ratio
24.603.925.738.12--
P/FCF Ratio
63.5518.32----
P/OCF Ratio
55.8915.10----
EV/Sales Ratio
18.183.415.9316.57--
EV/EBITDA Ratio
57.4311.58----
EV/EBIT Ratio
102.4222.29----
EV/FCF Ratio
63.9419.23----
Debt / Equity Ratio
0.690.680.690.360.070.06
Debt / EBITDA Ratio
1.501.80----
Debt / FCF Ratio
1.813.28----
Asset Turnover
0.480.400.270.210.15-
Inventory Turnover
33.6026.8012.256.096.11-
Quick Ratio
1.511.221.011.251.553.16
Current Ratio
1.891.531.251.521.963.49
Return on Equity (ROE)
16.11%4.12%-39.45%-50.12%-40.27%-
Return on Assets (ROA)
6.20%3.86%-6.94%-14.81%-14.02%-
Return on Capital (ROIC)
10.77%6.84%-12.56%-25.99%-22.52%-
Return on Capital Employed (ROCE)
12.10%8.00%-15.60%-27.60%-28.00%-18.10%
Earnings Yield
0.61%1.05%-8.82%-6.64%--
FCF Yield
1.57%5.46%-4.68%-6.00%--
Buyback Yield / Dilution
0.31%0.08%-4.54%-5.13%-180.82%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.